404 related articles for article (PubMed ID: 33602275)
21. Resource implications of preparing individual participant data from a clinical trial to share with external researchers.
Tudur Smith C; Nevitt S; Appelbe D; Appleton R; Dixon P; Harrison J; Marson A; Williamson P; Tremain E
Trials; 2017 Jul; 18(1):319. PubMed ID: 28712359
[TBL] [Abstract][Full Text] [Related]
22. Regulatory Frameworks for Clinical Trial Data Sharing: Scoping Review.
Gudi N; Kamath P; Chakraborty T; Jacob AG; Parsekar SS; Sarbadhikari SN; John O
J Med Internet Res; 2022 May; 24(5):e33591. PubMed ID: 35507397
[TBL] [Abstract][Full Text] [Related]
23. Intent to share Annals of Internal Medicine's trial data was not associated with data re-use.
Pellen C; Caquelin L; Jouvance-Le Bail A; Gaba J; Vérin M; Moher D; Ioannidis JPA; Naudet F
J Clin Epidemiol; 2021 Sep; 137():241-249. PubMed ID: 33915263
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials and the COVID-19 pandemic.
Retsas S
Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
[TBL] [Abstract][Full Text] [Related]
25. An assessment of the informative value of data sharing statements in clinical trial registries.
Ohmann C; Panagiotopoulou M; Canham S; Felder G; Verde PE
BMC Med Res Methodol; 2024 Mar; 24(1):61. PubMed ID: 38461273
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 and the need for stringent rules on data sharing.
Krishan K; Kanchan T
Acta Biomed; 2020 Dec; 92(1):e2021174. PubMed ID: 33682814
[TBL] [Abstract][Full Text] [Related]
27. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
28. A Comprehensive Analysis of Clinical Trials in the COVID-19 Pandemic Era.
Lee J; Shin HW; Lee JY; Kim JS; Yang JW; Lee KH; Kronbichler A; Shin JI
Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32604775
[No Abstract] [Full Text] [Related]
29. Merits of Data Sharing: The Digitalis Investigation Group Trial.
Angraal S; Ross JS; Dhruva SS; Desai NR; Welsh JW; Krumholz HM
J Am Coll Cardiol; 2017 Oct; 70(14):1825-1827. PubMed ID: 28958337
[No Abstract] [Full Text] [Related]
30. COVID-19-related medical research: a meta-research and critical appraisal.
Raynaud M; Zhang H; Louis K; Goutaudier V; Wang J; Dubourg Q; Wei Y; Demir Z; Debiais C; Aubert O; Bouatou Y; Lefaucheur C; Jabre P; Liu L; Wang C; Jouven X; Reese P; Empana JP; Loupy A
BMC Med Res Methodol; 2021 Jan; 21(1):1. PubMed ID: 33397292
[TBL] [Abstract][Full Text] [Related]
31. How does social presence influence public crisis information sharing intention? Situational pressure perspective.
Guo X; Jin H; Qi T
Front Public Health; 2023; 11():1124876. PubMed ID: 37497021
[TBL] [Abstract][Full Text] [Related]
32. An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).
Yeo-Teh NSL; Tang BL
Account Res; 2021 Jan; 28(1):47-53. PubMed ID: 32573274
[TBL] [Abstract][Full Text] [Related]
33. Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
Wu H; Dai R; He P; Liang J; Li Q; Yang J; Lu H; Guo Q; Mao W; Ji C
Int J Infect Dis; 2022 Mar; 116():210-215. PubMed ID: 35017106
[TBL] [Abstract][Full Text] [Related]
34. Research during the SARS-CoV-2 pandemic.
Muñoz de Nova JL; Ortega-Gómez M; Abad-Santos F;
Med Clin (Barc); 2021 Jan; 156(1):39-40. PubMed ID: 33268132
[No Abstract] [Full Text] [Related]
35. Rapid Publication, Knowledge Sharing, and Our Responsibility During the COVID-19 Pandemic.
Shah SS; Kulkarni N; Mahant S
J Hosp Med; 2020 May; 15(5):261. PubMed ID: 32379021
[No Abstract] [Full Text] [Related]
36. General medical publications during COVID-19 show increased dissemination despite lower validation.
Gai N; Aoyama K; Faraoni D; Goldenberg NM; Levin DN; Maynes JT; McVey MJ; Munshey F; Siddiqui A; Switzer T; Steinberg BE
PLoS One; 2021; 16(2):e0246427. PubMed ID: 33529266
[TBL] [Abstract][Full Text] [Related]
37. Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
Esmail LC; Kapp P; Assi R; Wood J; Regan G; Ravaud P; Boutron I
JAMA; 2023 May; 329(19):1695-1697. PubMed ID: 37010865
[TBL] [Abstract][Full Text] [Related]
38. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
Batta A; Khirasaria R; Kapoor V; Varshney D
J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
[TBL] [Abstract][Full Text] [Related]
40. A data-sharing agreement helps to increase researchers' willingness to share primary data: results from a randomized controlled trial.
Polanin JR; Terzian M
J Clin Epidemiol; 2019 Feb; 106():60-69. PubMed ID: 30342969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
